Brief: Sun Pharma Advanced Research Co Submits IND Application For SBO-154 To USFDA
March 31 (Reuters) - Sun Pharma Advanced Research Co Ltd SPRC.NS: SPARC SUBMITS IND APPLICATION FOR SBO-154 TO USFDA GLOBAL PHASE 1 STUDY PLANNED FOR SBO-154 IN SOLID TUMORS Source text: ID:nBSE9gDy0x Further company coverage: SPRC.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees